Skip to content

All recalls FDA

FDADrugsRecalled Status: Ongoing

Direct Rx recalls DULOXETINE D/R

Class IIofficial

FDA Class II

FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.

Hazard
CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit
Products
  • DULOXETINE D/R
Company
Direct Rx
Where it was sold

U.S. Nationwide

Nationwide

Units affected
263 Bottles
About this recall
DULOXETINE D/R, a) 30 mg (NDC 61919-482-30), 30 Caps; b) 30 mg (NDC 61919-482-60), 60 Caps; CYMBALTA, Packaged and Distributed by Direct Rx.